Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Korean Medical Science ; : 737-739, 2008.
Artigo em Inglês | WPRIM | ID: wpr-123473

RESUMO

The combination of atazanavir (ATV) and lopinavir/ritonavir (LPV/RTV) with nucleoside reverse transcriptase inhibitors (NRTI) has been used as a salvage regimen for human immunodeficiency virus (HIV)-positive patients. In this paper, we discuss two cases of HIV-positive patients who had long histories of virological failure following a heavy treatment of antiretroviral drugs, but then achieved virological suppression with double-boosted protease inhibitor (PI) regimens. In patients with multiple genotypic resistance to PIs and NRTIs, virological suppression can be achieved with a combination of ATV plus LPV/RTV with an NRTI backbone. The two cases in this report suggest that a combination of ATV plus LPV/RTV could be a useful salvage regimen for the subset of HIV-positive patients with limited treatment options.


Assuntos
Adulto , Humanos , Masculino , Farmacorresistência Viral Múltipla , Quimioterapia Combinada , Infecções por HIV/tratamento farmacológico , Inibidores da Protease de HIV/administração & dosagem , Oligopeptídeos/administração & dosagem , Piridinas/administração & dosagem , Pirimidinonas/administração & dosagem , Ritonavir/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA